Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Title
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Authors
Keywords
-
Journal
STROKE
Volume 48, Issue 4, Pages 970-976
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2017-02-18
DOI
10.1161/strokeaha.116.016275

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now